Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.7.2024MEDOCHEMIE Ltd. (MOE)0920CSiranalen 300 mg tvrdé kapsuly (cps dur 56x300 mg (blis.PVC/PVDC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)33199MEDOFLUCON 50 mg (cps dur 100x50 mg (blis.PVC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)3671CMEDOCLAV 400 mg/5 ml + 57 mg/5 ml prášok na perorálnu suspenziu (plu por 1x70 ml (fľ.skl.hnedá+dáv.striek.))15.7.2024R
 23.7.2024MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))15.7.2024R
 23.7.2024MEDOCHEMIE Ltd. (MOE)67030MEDOFLUCON 50 mg (cps dur 7x50 mg (blis.PVC/Al))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)67031MEDOFLUCON 150 mg (cps dur 10x150 mg (blis.PVC/Al))15.7.2024R
 23.7.2024MEDOCHEMIE Ltd. (MOE)67569MABRON 50 mg (cps dur 20x50 mg (blis.Al/PVC))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)67570MABRON 50 mg (cps dur 30x50 mg (blis.Al/PVC))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)8708DBROXIVAN 6 mg/ml perorálny roztok (sol por 1x200 ml/1200 mg (fľ.skl.hnedá+plast.odmer.))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)93335MABRON RETARD 150 (tbl plg 30x150 mg (blis.Al/PVC))15.7.2024O
 23.7.2024MEDOCHEMIE Ltd. (MOE)96084MEDOFLUCON 150 mg (cps dur 1x150 mg (blis.PVC/Al))15.7.2024O
 23.7.2024Zentiva k.s. (ZNT-3)6291DEverio Airmaster 50 mikrogramov/100 mikrogramov (plv ido 1x60 dávok (blis.Al/OPA/PVC+ inhalátor))30.9.2024Z
 23.7.2024Zentiva a.s. (ZNT-SK-2)33292Febira 200 (cps dur 60x200 mg (blis.PVC/PVDC/Al))30.9.2024Z
 23.7.2024Zentiva, k.s. (ZNT-1)0398CQuetiapin Zentiva SR 50 mg (tbl plg 60x50 mg (blis.PVC/PCTFE/Al))23.7.2024Z
 23.7.2024Zentiva, k.s. (ZNT-1)0410CQuetiapin Zentiva SR 200 mg (tbl plg 60x200 mg (blis.PVC/PCTFE/Al))30.9.2024Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To